NCT03142204View on ClinicalTrials.gov

[18F]FAraG PET Imaging for Analysis of Biodistribution in Cancer Patients Expected to Undergo Immunotherapy and/or Radiation Therapy

PHASE1UnknownINTERVENTIONAL
Enrollment

30

Participants

Timeline

Start Date

May 1, 2017

Primary Completion Date

May 31, 2024

Study Completion Date

May 31, 2024

Conditions
Cancer
Interventions
DRUG

[18F]F-AraG

Single dose IV injection of \[18F\]F-AraG for each imaging day.

Trial Locations (1)

94107

RECRUITING

UCSF Imaging Center at China Basin, San Francisco

Sponsors
All Listed Sponsors
collaborator

UCSF Imaging Center at China Basin

UNKNOWN

lead

CellSight Technologies, Inc.

INDUSTRY

NCT03142204 - [18F]FAraG PET Imaging for Analysis of Biodistribution in Cancer Patients Expected to Undergo Immunotherapy and/or Radiation Therapy | Biotech Hunter | Biotech Hunter